Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Satoko Ito, Karthik Chetlapalli, Daniel Wang, Kunal C. Potnis, Rhys Richmond, Harlan M. Krumholz, Alfred I. Lee, Adam Cuker, George Goshua

Blood (2025) 145 (1): 127–140.

https://doi.org/10.1182/blood.2024025176

Published: 2025

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Kunal C Potnis, Satoko Ito, Kishan Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Scott F Huntington, Maximilian Stahl, Amer M. Zeidan, Jan Philipp Bewersdorf, George Goshua

Blood (2024) 144 (Supplement 1): 3644.

https://doi.org/10.1182/blood-2024-204312

Published: 2024

Journal Articles

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Samira Glaeser-Khan, Rhys Richmond, Satoko Ito, Robert D Bona, Harlan M. Krumholz, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 157.

https://doi.org/10.1182/blood-2024-203690

Published: 2024

Journal Articles

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Karthik Chetlapalli, Ayesha Butt, Satoko Ito, Daniel Wang, Cecelia Calhoun, Lakshmanan Krishnamurti, Ankur Pandya, George Goshua

Blood (2024) 144 (Supplement 1): 601.

https://doi.org/10.1182/blood-2024-203234

Published: 2024

Journal Articles

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Daniel Wang, Daniel Y Wang, Samira Glaeser-Khan, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 281.

https://doi.org/10.1182/blood-2024-198803

Published: 2024

Journal Articles

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Daniel Wang, Samira Glaeser-Khan, Daniel Y Wang, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 277.

https://doi.org/10.1182/blood-2024-203654

Published: 2024

Journal Articles

Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)

Lauren E. Merz, Satoko Ito, Kelly J. Walkovich, Maureen Achebe, Nathalie Van Havre, Patricia Frustace, George Goshua

Blood (2024) 144 (Supplement 1): 162.

https://doi.org/10.1182/blood-2024-202605

Published: 2024

Journal Articles

Identifying Patients with Erythrocytosis Not Requiring JAK2 Testing: External Validation and Decision Analysis of the Jakpot Prediction Rule

Barbara D Lam, Satoko Ito, Justine Ryu, Kevin O'Sullivan, Kunal C Potnis, Roosevelt Lu, Aram Bidikian, Jason A Freed, Jennifer La, George Goshua

Blood (2024) 144 (Supplement 1): 3669.

https://doi.org/10.1182/blood-2024-198033

Published: 2024

Journal Articles

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D. Bona, Adam Cuker, George Goshua

Blood (2024) 143 (22): 2332–2335.

https://doi.org/10.1182/blood.2024024209

Published: 2024

Includes: Supplemental data

Journal Articles

Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding

Daniel Wang, Satoko Ito, Christina Waldron, Ayesha Butt, Ellen Zhang, Harlan M. Krumholz, Hanny Al-Samkari, George Goshua

Blood (2023) 142 (Supplement 1): 2312.

https://doi.org/10.1182/blood-2023-185340

Published: 2023

Journal Articles

Setting Cost-Effective Price Thresholds before FDA Approval: Cost-Effectiveness of Iptacopan Monotherapy Versus Standard-of-Care Anti-C5 Therapy in Transfusion-Dependent, Treatment-Experienced Adult Patients with Paroxysmal Nocturnal Hemoglobinuria in the United States

Satoko Ito, Karthik Chetlapalli, Kunal C Potnis, Rhys Richmond, Daniel Wang, Alfred I Lee, George Goshua

Blood (2023) 142 (Supplement 1): 5042.

https://doi.org/10.1182/blood-2023-188063

Published: 2023

Journal Articles

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 2316.

https://doi.org/10.1182/blood-2023-187270

Published: 2023

Journal Articles

Second-Line Therapy Sequencing in Primary Warm Autoimmune Hemolytic Anemia: Splenectomy-Rituximab Versus Rituximab-Splenectomy

Christina Waldron, Satoko Ito, Daniel Wang, Giri Viswanathan, Ayesha Butt, George Goshua

Blood (2023) 142 (Supplement 1): 2317.

https://doi.org/10.1182/blood-2023-189957

Published: 2023

Journal Articles

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 368.

https://doi.org/10.1182/blood-2023-184927

Published: 2023

Journal Articles

Equitable Care for Severe Hemophilia_A: Distributional Cost-Effectiveness of Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in Patients with Severe Hemophilia_A in the United States

Satoko Ito, Kunal C Potnis, Cecily Allen, Rhys Richmond, Christina Waldron, Giri Viswanathan, Robert D Bona, George Goshua

Blood (2023) 142 (Supplement 1): 492.

https://doi.org/10.1182/blood-2023-190420

Published: 2023

Journal Articles

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

George Goshua, Satoko Ito, Karthik Chetlapalli, Kunal C Potnis, Cecelia Calhoun, Lakshmanan Krishnamurti, Harlan M. Krumholz, Ankur Pandya

Blood (2023) 142 (Supplement 1): 490.

https://doi.org/10.1182/blood-2023-191072

Published: 2023

Journal Articles

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2023-188018

Published: 2023

NARROW

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)

Identifying Patients with Erythrocytosis Not Requiring JAK2 Testing: External Validation and Decision Analysis of the Jakpot Prediction Rule

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding

Setting Cost-Effective Price Thresholds before FDA Approval: Cost-Effectiveness of Iptacopan Monotherapy Versus Standard-of-Care Anti-C5 Therapy in Transfusion-Dependent, Treatment-Experienced Adult Patients with Paroxysmal Nocturnal Hemoglobinuria in the United States

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Second-Line Therapy Sequencing in Primary Warm Autoimmune Hemolytic Anemia: Splenectomy-Rituximab Versus Rituximab-Splenectomy

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Equitable Care for Severe Hemophilia_A: Distributional Cost-Effectiveness of Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in Patients with Severe Hemophilia_A in the United States

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only